MedPath
TGA Approval

BREO ELLIPTA fluticasone furoate 200 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation (199747)

199747

BREO ELLIPTA fluticasone furoate 200 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation

GlaxoSmithKline Australia Pty Ltd

April 17, 2014

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/39a2a6e5d12cb2e8347c40f4ac539ddb.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/8007421e33761e33f2673d807a6aa2f1.pdf

Active Ingredients

fluticasone furoate

vilanterol trifenatate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BREO ELLIPTA fluticasone furoate 200 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation (199747) - TGA 批准文号 | MedPath